2.36 Thought Leaders, NELSON, & Reliance on P Values in Cancer Trials with Dr. Sam Rubinstein
This week we discuss the concept of "thought lead…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
February 7, 202059m 11sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week we discuss the concept of "thought leaders" and we examine the conclusions about volume CT screening for lung cancer from the NELSON trial. We end with an interview with Dr. Sam Rubinstein, a hematology/oncology fellow at Vanderbilt University Medical Center, on his new paper published in JAMA Network Open titled "Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysis".
NELSON: doi.org/10.1056/NEJMoa1911793
Measures of Uncertainty: doi.org/10.1001/jamanetworkopen.2019.17530
Back us on Patreon! www.patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy